Objective Patients with breast cancer face cognitive impairment that affects their quality of
life; partially attributable to treatment. Our aim was to detail the prevalence and change of …

The mechanism (s) for chemotherapy-induced cognitive changes are largely unknown;
however, several candidate mechanisms have been identified. We suggest that shared …

Introduction Mild cognitive impairment following chemotherapy is one of the most commonly
reported post treatment symptoms by breast cancer survivors. This deterioration in cognitive …

Many cancer patients treated with chemotherapy develop chemotherapy-induced cognitive
impairment (CICI), often referred to as chemo-brain, which manifest during or post-treatment …

Breast cancer is the most common malignant tumor affecting women. Adjuvant systemic
therapies have been shown to have a significant impact on reducing the risk for breast …

BACKGROUND Chemotherapy‐induced cognitive dysfunction in patients with breast
carcinoma has been described previously. However, those studies only assessed patients' …

OBJECTIVE: Several studies have identified that adjuvant chemotherapy for breast cancer is
associated with cognitive impairment; however, the magnitude of this impairment is unclear …

A meta-analysis was conducted to evaluate possible neuropsychological effects of
treatments for cancer in adults. A search revealed 30 studies, encompassing 29 eligible …

Purpose There is evidence that some cancer survivors suffer cognitive impairment after
chemotherapy. Determining if a patient has cognitive impairment is challenging, especially …

Purpose The use of chemotherapy and endocrine therapies in the treatment of
premenopausal women carries with it reproductive and gynecologic implications that young …